coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Horsham Central PCN, Horsham · Health Inequalities Profile

    PCN U26939 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 2 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    27,887

    Registered population

    61.1% aged 18–64

    19.3%

    Aged 65+

    ICB 21.9% · England 17.9%

    8.8%

    Ethnic minority (non-White)

    4.0% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    4,148

    Hypertension register

    +2.06% in 3 yrs · England +5.60%

    195

    SMI register

    15.4% of Horsham's

    331

    COPD register

    Reviews +8.39% in 3 yrs

    Forecast to 2030

    4,875

    Hypertension patients, 2030

    +727 on today

    81.8%

    QRISK ≥20% on statins, 2030

    +7.66pp over 3 yrs

    4.5%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    56.5%
    Asthma annual reviews trail benchmarks and fell.

    Annual reviews reached 56.5% (Horsham 62.4%, England 65.7%), falling 2.8% over 2023 to 2025 and leaving about 720 of 1,663 patients unreviewed.

    31.5 pp
    Wide practice divergence on phone access and vaccines.

    Easy phone contact ranges 31.5 pp from 47.0% at Riverside Medical Practice to 78.6% at Holbrook Surgery, matching a 31.5 pp QOF vaccination gap.

    +13.8%
    Lipid therapy and COPD reviews outpaced England.

    Over 2023 to 2025, QRISK ≥ 20% lipid therapy rose +13.8% (England +6.2%) to 63.2%, and COPD reviews rose +8.4% to 79.2%.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    At 19.3%, older adult share trails Horsham despite projected 7.4% list growth

    Horsham Central PCN registers 27,887 patients across Holbrook Surgery (16,417) and Riverside Medical Practice (11,470). Patients aged 65+ comprise 19.3% (5,384 patients), below Horsham (23.7%) and NHS Sussex Integrated Care Board (21.9%), but above England (17.9%). Projected list growth to 2030 is 7.4% under an unverified methodology, exceeding Horsham (4.4%), NHS Sussex Integrated Care Board (2.1%) and England (2.3%). Census usual residents are 91.2% White, below Horsham (93.6%), in line with NHS Sussex Integrated Care Board (91.0%) and above England (81.1%), with an 8.8% ethnic minority share. Registered patient counts differ from Census resident ethnicity bases.

    Age profile

    0–1719.6%
    18–6461.1%
    65+19.3%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White91.2%
    Asian4.0%
    Mixed2.7%
    Black1.4%
    Other0.8%

    Older people · falls rows are Horsham local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Horsham LA)2,1542,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)82.1%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)62.4%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Horsham LA)9099819552024/25
    Falls deaths, all ages, per 100,000 (Horsham LA)10.514.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average IMD decile is 8.5 and Core20 share is 0.0% across both member practices

    The PCN has an average IMD decile of 8.5, indicating low overall deprivation against Horsham (8.2), NHS Sussex Integrated Care Board (6.1) and England (5.5). Its Core20 share is 0.0% (0 patients), matching Horsham (0.0%) but below NHS Sussex Integrated Care Board (9.2%) and England (21.0%). Core20 share is 0.0% at Riverside Medical Practice (IMD decile 8.3) and 0.0% at Holbrook Surgery (decile 8.6). Area deciles do not preclude individual disadvantage among the 27,887 registered patients.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Riverside Medical0.0% · 0 patients
    Holbrook0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    195

    SMI register

    0.70% recorded prevalence

    125

    Learning disability register

    0.45% recorded prevalence

    20

    Care homes, 871 beds

    In the PCN catchment

    8.0%

    Provide unpaid care

    Horsham, Census 2021

    The PCN records 195 patients on the severe mental illness register (0.7%) and 125 with learning disabilities (0.5%). The catchment includes 20 care homes with 871 beds. Horsham district recorded 9 rough sleepers in 2025, while its 8.0% unpaid carer rate yields an estimated PCN ceiling of 2,231 unpaid carers. District and bed figures do not establish registered patient headcounts.

    Severe mental illness: physical health checks

    SMI blood pressure checks reached 85.1% (England 83.4%), yet fell 1.2 pp over 2023 to 2025 (England +4.4 pp). At Riverside Medical Practice, checks fell 7.0 pp over 2023 to 2025.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    4,148

    Hypertension register

    +2.06%

    Register growth, 3 yrs

    Horsham +4.65% · England +5.60%

    −1.00pp

    BP control, under 80

    ≤140/90 · +0.77pp aged 80+

    +727

    More patients by 2030

    Forecast 4,875 (15.55%)

    Hypertension case-finding and control

    Hypertension recorded prevalence is 14.9% (register 4,148), below Horsham (16.8%) and England (15.2%), rising +0.3 pp over 2023 to 2025 (England +0.8 pp). Unadjusted benchmark scenarios indicate a register gap of +99 to +531 patients. Hypertensive patients with a recent blood pressure reading reach 87.6%, behind Horsham (92.0%) and England (90.0%). Blood pressure control under age 80 is 68.0%, below Horsham (71.5%) and above England (67.8%), having fallen 1.0 pp over 2023 to 2025 (England +2.1 pp). Control is 69.3% at Riverside Medical Practice and 67.0% at Holbrook Surgery. Lower control than the borough highlights an opportunity to review recall and medication titration.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy reached 63.2%, below England (63.6%) and above Horsham (62.1%), following a gain of +7.7 pp over 2023 to 2025 (England +3.8 pp). Achievement was 68.8% at Riverside Medical Practice and 59.5% at Holbrook Surgery.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202628,692£4.00£2.42£1.86£114,768
    Cardiovascular (all), 202536,321£4.51£3.32£3.33£163,808

    In 2026, 28,692 lipid-regulating drug items were prescribed at £4.00 per item, above Horsham (£2.64) and England (£1.86), while prescribing for persons aged 18+ was 1,280 items per 1,000 (England 4,100). Across 28,692 items, the PCN spends £61,401 more than at England's unit cost.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −2.78%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +2.92%

    Asthma prevalence, PCN 3-yr % change

    Asthma reviews fell 2.8% over 2023 to 2025 (England +4.4%) to 56.5%, trailing Horsham (62.4%) and England (65.7%), leaving about 720 of 1,663 patients unreviewed. Second-hand smoke recording for asthma patients aged 6-19 reached 73.4% (England 78.8%), while asthma drug prescribing for ages 5-19 was 704 per 1,000 (England 1,488). COPD reviews rose +8.4% over 2023 to 2025 (England +2.8%) to 79.2% (England 76.4%), with COPD prevalence at 1.2% (England 1.9%).

    Cancer register and children's immunisation

    Cancer register prevalence is 3.9% (1,072 patients), in line with England (3.8%) and below Horsham (5.1%). In childhood immunisation, age-5 MMR1 reached 100.0%, but MMR2 dropped 6.1 pp to 93.9% and the 4-in-1 booster reached 92.4%, both trailing the 95.0% target. At Riverside Medical Practice, the MMR dose drop was 10 pp, while at Holbrook Surgery it was 2.8 pp. Targeted pre-school recall is required to close second-dose immunisation gaps.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months96.1%

    England 91.0%

    6-in-1 complete primary course at 24 months98.8%

    England 92.2%

    MMR dose 1 at 24 months97.6%

    England 88.3%

    MMR dose 2 at age 593.9%

    England 82.8%

    4-in-1 pre-school booster at age 592.4%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    In 2022, NHS Sussex ICB diagnosed 58.5% of cancers at stage 1 or 2 among cases with a known stage (4,799 of 8,209), above England (55.3%) but 16.5 pp below the 75.0% national ambition by 2028. Staging completeness reached 64.3% (8,209 of 12,766; England 67.0%), requiring about 1,360 extra early diagnoses annually across the ICB. While ICB staging reflects wider system pathways rather than PCN performance, PCN cancer register growth (+7.9%) trailed England (+9.0%), diverging between practices: falling 2.1% at Riverside Medical Practice while rising +14.6% at Holbrook Surgery. Diverging practice trends may reflect coding differences or referral patterns (unverified locally), making register safety-netting audits an operational priority.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), Surrey and Sussex Healthcare NHS Trust achieved 70.0% on the 62-day cancer standard, below the 85.0% standard by 15.0 pp, against 84.5% at Royal Surrey NHS Foundation Trust, 65.2% at University Hospitals Sussex NHS Foundation Trust, 71.5% across NHS Surrey and Sussex Integrated Care Board, and 71.2% in England. Its 28-day faster diagnosis rate reached 77.7% (standard 75.0%; England 79.3%). Diagnostic 6+ week waits were 28.5% at Surrey and Sussex Healthcare NHS Trust, above Royal Surrey NHS Foundation Trust (8.8%), University Hospitals Sussex NHS Foundation Trust (12.9%), and England (23.1%).

    Pathways within standard (%)Surrey and Sussex HealthcareSussexRoyal SurreySurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)77.7474.0182.6279.2979.32
    31-day treatment (96%)96.2076.7996.4390.4592.50
    62-day referral to treatment (85%)69.9765.2084.4871.5171.16
    Diagnostic waits over 6 weeks (%)Surrey and Sussex HealthcareSussexRoyal SurreyEngland
    MRI27.535.620.0021.40
    CT18.498.570.159.92
    Echocardiography43.780.391.5528.48
    Colonoscopy15.1139.350.0030.83
    Gastroscopy21.0620.020.0029.02
    All 15 DM01 tests28.5012.958.8223.14
    Community services activityWest Sussex residentsSurrey and Sussex ICB
    Care contacts78,050309,615
    Referrals16,01566,930
    Patients with a contact19,77085,660

    Community services (residents of West Sussex), Jun 2026 (provisional). In Jun 2026 (provisional), West Sussex residents recorded 78,050 community care contacts across 19,770 patients, contributing to 309,615 contacts across NHS Surrey and Sussex Integrated Care Board. Contacts with adults aged 65+ accounted for 72.7% of West Sussex contacts (56,740 of 78,050). These experimental figures reflect local authority resident and system activity rather than unique PCN patient contacts.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access and vaccination achievement diverge by 31.5 percentage points between practices

    In 2025/26, clinical QOF achievement reached 99.6% at Riverside Medical Practice and 99.5% at Holbrook Surgery (England 97.1%). Vaccination and immunisation achievement diverged by 31.5 pp, from 79.8% at Holbrook Surgery to 48.3% at Riverside Medical Practice (England 55.2%). Strong chronic disease management sits alongside marked inter-practice divergence in immunisation delivery.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Holbrook Surgery1040.078.6%65.5%91.7%
    Riverside Medical1220.047.0%55.7%70.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNHorshamAssetPCNHorsham
    Care homes (catchment)20 (871 beds)n/aSchools (catchment)48n/a
    Children's centres69Places of worship3593
    Libraries17Homelessness support (VCS)0no data
    Day centres (VCS)47Children and young people (VCS)n/a1
    Carers support groups (VCS)12Primary schools (LA maintained)1637
    Primary academies26Special schools23

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Asthma annual review recall

    Asthma reviews reached 56.5% (register 1,663), below Horsham (62.4%) and England (65.7%), falling 2.8% over 2023 to 2025 (England +4.4%) and leaving 723 (about 720) patients unreviewed. For discussion: the PCN could run structured asthma recall using a single review template and flexible appointment slots. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Hypertension case-finding and register audit

    Hypertension prevalence is 14.9% (register 4,148), below England (15.2%) and Horsham (16.8%), giving an unadjusted gap of +99 to +531 patients across the 27,887 list. For discussion: practices could search records for repeated raised blood pressure readings without a hypertension diagnosis code and offer opportunistic checks. Low cost, quick to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 3

    Dementia and learning disability register validation

    Dementia prevalence is 0.4% (113 patients, down 2.4% vs England +6.0%; unadjusted gap +105 to +147) and learning disability is 0.5% (125, down 7.9% vs +5.4%; gap +15 to +39). For discussion: practices could audit diagnostic coding and validate registers against existing clinical and care home records. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult capacity planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Nonspatial vulnerability screening (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall audit (p4)Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Hypertension recall and titration review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR recall targeting (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cancer register coding audit (p7)Cancer: QOF prevalenceCore20PLUS5, 75% stage 1–2 by 2028PCN
    Telephony and triage workflow review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · Hypertension case-finding and register audit (p12)Hypertension register · Hypertension: QOF prevalence · Aged 65+Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 3 · Dementia and learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence · Dementia register75% annual health checks (Network Contract DES) · Oliver McGowan · 66.7% diagnosis ambition · 95% care plan 2027PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15